Andreas Fibig to leave Bayer HealthCare Pharmaceuticals

Will join International Flavors & Fragrances in New York on 1 September

Andreas Fibig, President of Bayer HealthCare Pharmaceuticals and a member of the Bayer HealthCare Executive Committee, will leave the company to become Chief Executive of International Flavors & Fragrances, New York, NY, US, effective from 1 September.

Olivier Brandicourt, CEO of Bayer HealthCare, said Fibig has helped the company's pharmaceutical business to become one of the fastest-growing in the industry over the past few years.

'We thank him and wish him all the best for his next step in his career and his future,' he said.

The company will announce a successor for Fibig shortly.

You may also like

Ingredients

An effective micronutrient supplement for mental performance and energy release

Physical stamina and mental acuity are both important for achievement-driven individuals to perform
Ingredients

Vitamin Bee teams up with Bayer bee care programme for feed a bee initiative

Feed a Bee partner Vitamin Bee promotes the importance of healthy honey bees to a nutritious diet
Ingredients

Bayer HealthCare launches Beauty is Bone Deep

Women encouraged to focus on bone health as the foundation of beauty as they age
Ingredients

Swedencare's dog soft chew, ProDen PlaqueOff, gains Vetinary Oral Health Council seal of approval

The supplement, which contains Swedencare's A.N ProDen seaweed ingredient, is designed to control plaque and tartar in dogs
Ingredients

Omega-3 and omega-6 intake could reduce a person's risk of developing cancer, study finds

Higher intake of both omega-3 and omega-6 can reduce an individual's risk of 19 different cancers, though this impact varied based on sex and age and omega-3/6 ratios
Manufacturing

Happy Plant Protein secures €1.8m to develop and license its plant-based protein ingredients

The manufacturing process developed by Happy Plant Protein can reduce plant-based protein production costs by up to 90%, while also creating functional food products with a 70–80% protein content
Training & Education

Gnosis by Lesaffre's Vitamin K2 Scientific Advisory Committee share this year's findings

In the K2SAC's third meeting, experts discussed the potential of vitamin K2 in healthy ageing and cognitive health, while also looking at necessary future endeavours
Subscribe now